Artelo BiosciencesARTL
13F holders, Q2 2025 (June 30)9holders
$13.27avg. 13F price*
At the end of Q2 2025, 9 institutions reported holding Artelo Biosciences Inc. (ARTL) in their 13F filings. The largest holders were Geode Capital Management, LLC ($213K), Tower Research Capital LLC (TRC) ($6K) and UBS Group AG ($1K).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G607
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $220K |
| Exits | 0 | $0 |
Ownership 9 holders
| Geode Capital Management, LLC | 0.00% | New | 16,032 | $213K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 447 | $6K |
| UBS Group AG | 0.00% | New | 89 | $1K |
| Citigroup Inc. | 0.00% | New | 9 | $119 |
| Bank of America Corp. | 0.00% | New | 5 | $66 |
| Morgan Stanley | 0.00% | New | 4 | $53 |
| FMR LLC | 0.00% | New | 1 | $13 |
| Danske Bank A/S | 0.00% | New | 1 | $13 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is ARTL's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.